CorMedix Inc. (CRMD) Financials

$9.10

south_east
-$0.05 (-0.55%)
Day's range
$8.94
Day's range
$9.2
$60M$60M$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201820182019201920202020202120212022202220232023202420240%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%-60000%-60000%Profit Margin
Profit Margin
Revenue
Earnings

CRMD Income statement / Annual

Last year (2024), CorMedix Inc.'s total revenue was $43.47 M, and the percentage change from the previous year is not available. In 2024, CorMedix Inc.'s net income was -$17.93 M. See CorMedix Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $43.47 M $0.00 $65,408.00 $190,936.00 $239,231.00 $283,266.00 $429,797.00 $329,327.00 $224,105.00 $210,130.00
Cost of Revenue $3.19 M $205,562.00 $3,734.00 $148,938.00 $204,846.00 $373,234.00 $396,786.00 $114,964.00 $366,673.00 $318,718.00
Gross Profit $40.28 M -$205,562.00 $61,674.00 $41,998.00 $34,385.00 -$89,968.00 $33,011.00 $214,363.00 -$142,568.00 -$108,588.00
Gross Profit Ratio 0.93 0 0.94 0.22 0.14 -0.32 0.08 0.65 -0.64 -0.52
Research and Development Expenses $3.94 M $13.16 M $10.68 M $13.13 M $13.38 M $11.05 M $18.82 M $24.49 M $15.74 M $6.28 M
General & Administrative Expenses $29.96 B $0.00 $0.00 $0.00 $0.00 $0.00 $8.07 M $8.65 M $8.88 M $10.26 M
Selling & Marketing Expenses -$28.74 B $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $58.70 M $35.80 M $20.01 M $16.35 M $13.88 M $9.87 M $8.07 M $8.65 M $8.88 M $10.26 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $62.64 M $48.96 M $30.69 M $29.48 M $27.26 M $20.92 M $26.90 M $33.14 M $24.62 M $16.55 M
Cost And Expenses $65.83 M $48.96 M $30.69 M $29.48 M $27.46 M $21.29 M $27.29 M $33.25 M $24.99 M $16.86 M
Interest Income $2.58 M $0.00 $326,016.00 $14,403.00 $116,065.00 $322,668.00 $36,618.00 $110,714.00 $126,774.00 $60,393.00
Interest Expense $36,405.00 $0.00 $26,515.00 $15,943.00 $33,226.00 $787,488.00 $1,873.00 $5,619.00 $1,311.00 $3,964.00
Depreciation & Amortization -$22.34 B $70,755.00 $209,038.00 $177,020.00 $143,487.00 $73,286.00 $74,218.00 $36,886.00 $25,596.00 $15,076.00
EBITDA -$22.36 B -$48.89 M -$30.05 M -$29.38 M -$27.02 M -$20.63 M -$26.75 M -$32.97 M -$24.62 M -$18.17 M
EBITDA Ratio -514.27 0 -459.45 -153.85 -112.95 -72.84 -62.25 -100.12 -109.85 -86.46
Operating Income Ratio -0.51 0 -468.2 -154.18 -113.78 -74.16 -62.5 -99.97 -110.49 -79.26
Total Other Income/Expenses Net -$19.30 B $2.62 M $336,646.00 -$22,827.00 $23,674.00 -$485,976.00 $34,566.00 -$85,804.00 $117,291.00 -$1.53 M
Income Before Tax -$19.32 B -$46.34 M -$30.29 M -$29.46 M -$27.20 M -$21.49 M -$26.83 M -$33.01 M -$24.64 M -$18.19 M
Income Before Tax Ratio -444.53 0 -463.05 -154.29 -113.69 -75.88 -62.42 -100.23 -109.96 -86.55
Income Tax Expense -$1.39 B $0.00 -$585,617.00 -$1.25 M -$5.17 M -$5.06 M $36,439.00 -$31,267.00 $1,311.00 $3,964.00
Net Income -$17.93 M -$46.34 M -$29.70 M -$28.21 M -$22.03 M -$16.43 M -$26.83 M -$33.01 M -$24.64 M -$18.19 M
Net Income Ratio -0.41 0 -454.1 -147.75 -92.08 -58.01 -62.42 -100.23 -109.96 -86.55
EPS -0.3 -0.91 -0.74 -0.75 -0.77 -0.68 -1.51 -2.99 -3.25 -2.9
EPS Diluted -0.3 -0.91 -0.74 -0.75 -0.77 -0.68 -1.51 -2.99 -3.25 -2.9
Weighted Average Shares Out $58.87 M $50.90 M $40.14 M $37.61 M $28.56 M $24.15 M $17.82 M $11.03 M $7.59 M $6.27 M
Weighted Average Shares Out Diluted $58.87 M $50.90 M $40.27 M $37.67 M $28.56 M $24.15 M $17.82 M $11.03 M $7.59 M $6.27 M
Link